CRP and inflammatory bowel disease: Although physicians can assess clinical disease activity of patients by asking questions about IBD-related symptoms, they often rely on one or more biomarkers (CRP, ESR, and FC) to provide an additional reference in the assessment of overall disease activity and drug responses.